Professional Documents
Culture Documents
• Narrow-spectrum Antibiotics
• Antibiotics that can destruct either Gram positive or
Gram negative bacteria.
• e.g. vancomycin work on Gram positive bacteria only.
colistin work on Gram negative bacteria only
• Broad-spectrum Antibiotics
• Antibiotics that can destruct Both Gram positive and Gram
negative bacteria.
• e.g. Ampicillin.
MULTIDRUG THERAPY
Synergism Antagonism
• Is when 2 antimicrobial agent are • Is when 2 drugs actually work
used together to produce a degree against each other. The extent of
of pathogen killing that is greater pathogens killing less than that
than that achieved by either drug achieved by either drug alone.
alone.
ANTIFUNGAL AGENT
• Most antifungal agents work in one of 3 ways:
• By binding with cell membrane sterols (e.g., nystatin and amphotericin
B)
• By interfering with sterol synthesis (e.g., clotrimazole and miconazole)
• By blocking mitosis or nucleic acid synthesis (e.g., griseofulvin and 5-
flucytosine).
ANTIPROTOZOAL AGENT
• Antiprotozoal drugs are usually quite toxic to the host.
• Anti protozoal agent works by:
• (a) interfering with DNA and RNA synthesis (e.g.,
chloroquine, pentamidine, and quinacrine),
• (b) interfering with protozoal metabolism (e.g.,
metronidazole; brand name Flagyl).
ANTIVIRAL AGENTS
• Antiviral agents are the newest weapons in antimicrobial
methodology.
• difficult to develop and use because viruses are produced within host
cells.
• Some drugs have been developed that are effective in certain viral
infection, but not others; they work by inhibiting viral replication cell.
• e.g. Acyclovir for the treatment of HSV.
• “cocktail” of drugs including lamivudine for HIV.
DRUG RESISTANCE
(SUPERBUGS)
• Superbugs are microbes(bacteria) that have
become resistant to one or more antimicrobial
agent.
• Infections caused by superbugs are much
more difficult to treat.
DRUG RESISTANT
• Bacterial superbugs include:
• Methicillin-resistant S. aureus (MRSA)
• Vancomycin-resistant Enterococcus spp. (VRE)
• Multidrug-resistant M. tuberculosis (MDR-TB)
• Multidrug-resistant strains of Acinetobacter baumannii, Burkholderia
cepacia, E. coli, Klebsiella pneumoniae, N. gonorrhoeae,
• • β-Lactamase–producing strains of S. pneumoniae and Haemophilus
influenza
DRUG RESISTANCE
(HOW BACTERIA BECOME RESISTANT
TO DRUGS)
Intrinsic Resistance
• Some bacteria are naturally resistant to a particular
antimicrobial agent because they lack the specific
target site for that drug or the drug is unable to cross
the organism’s cell wall or cell membrane and, thus,
cannot reach its site of action.
• Acquired Resistance
• Bacteria can acquire resistance by one of these
methods:
DRUG RESISTANCE
• Before a drug can enter a bacterial cell, molecules of the
drug must first bind (attach) to proteins on the surface of the
cell; these protein molecules are called drug binding sites.
• A chromosomal mutation can result in an alteration in the
structure of the drug-binding site, so that the drug is no
longer able to bind to the cell. If the drug cannot bind to
the cell, it cannot enter the cell, and the organism is,
therefore, resistant to the drug.
DRUG RESISTANCE